Michael Fulmer's journey back to the big leagues is a captivating tale of resilience and second chances. Can he reclaim his former glory?
The San Francisco Giants have offered a lifeline to Fulmer, a once-promising pitcher whose career has been plagued by injuries. With a minor league deal, the Giants are betting on Fulmer's potential to resurrect his MLB career, and he's eager to prove them right.
Fulmer's last impactful season was in 2023 with the Chicago Cubs, where he showcased versatility with a 3-5 record, a 4.42 ERA, and 65 strikeouts in 58 games. But a significant setback followed—UCL revision surgery on his pitching elbow, wiping out his entire 2024 season. This wasn't his first encounter with elbow issues; he underwent Tommy John surgery in 2019 while with the Detroit Tigers.
And here's where his story takes a twist. The Boston Red Sox signed Fulmer in 2024, knowing he'd miss the season. After a brief stint in Triple-A, he joined the Red Sox roster in 2025, only to be designated for assignment after one game. Fulmer then embarked on a journeyman's path, briefly returning to the Cubs, signing with the Kansas City Royals, and later the Seattle Mariners, where he excelled with a 0.75 ERA in 12 innings.
The Giants are now betting on Fulmer's experience and past success. As a rookie, he dazzled with an 11-7 record and a 3.06 ERA, earning the AL Rookie of the Year award. The following season, he made the All-Star Game. But injuries have since limited his role, primarily as a reliever. From 2021-22, he was effective with a 3.17 ERA in 119 games, and the Giants aim to unlock that potential again.
But is Fulmer's best already behind him? The Giants hope to prove the doubters wrong, believing he can be a reliable setup man. This story of redemption is one to follow, as Fulmer strives to reclaim his place in the MLB spotlight. Will he rise again, or is this a long shot? Share your thoughts on this comeback attempt and the Giants' strategy in the comments below!
